Literature DB >> 19927355

Prevalence characterization of extended-spectrum beta-lactamases among Escherichia coli isolates collected in Zhengzhou.

Zhijian Zhang1, Xiaobing Guo, Qinxian Zhang.   

Abstract

OBJECTIVES: To determine the prevalence and the diversity of extended-spectrum beta-lactamases (ESBLs) among Escherichia coli isolates in Zhengzhou, China.
METHODS: Clinical isolates were collected and investigated from the first affiliated hospital of Zhengzhou University and its associated health-care facilities in Zhengzhou, China, during the period from January 2006 to June 2008. Antibiograms were performed on Mueller-Hinton agar plates with the disc-diffusion method and MICs were determined by the agar-dilution method. Total DNA was extracted with a Qiagen mini kit and screened by PCR.
RESULTS: Of 94 nonduplicate ESBL-positive isolates, TEM-type was encoded in 74 and 79% of the ESBL isolates. Fifty-six isolates were SHV type ESBLs. CTX-M-1, CTX-M-14, CTX-M-25, and CTX-M-38 types were encoded in 30, 54, 6, and 4, respectively. OXA-1-type beta-lactamases were encoded in six and OXA-20-type was encoded in two isolates.
CONCLUSIONS: We describe a complex ESBL epidemiology. The study revealed a high rate of ESBL-producing E. coli isolates. TEM and CTX-M enzymes dominated in ESBL-positive E. coli isolates in Zhengzhou, China.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19927355      PMCID: PMC6649103          DOI: 10.1002/jcla.20351

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  23 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 2.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

3.  Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region.

Authors:  P L Winokur; R Canton; J M Casellas; N Legakis
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

4.  Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme.

Authors:  M Gniadkowski; I Schneider; A Pałucha; R Jungwirth; B Mikiewicz; A Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

5.  Clonal dissemination of a CTX-M-15 beta-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui.

Authors:  M Lavollay; K Mamlouk; T Frank; A Akpabie; B Burghoffer; S Ben Redjeb; R Bercion; V Gautier; G Arlet
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

6.  Prevalence of beta-lactams resistance among Escherichia coli clinical isolates from a hospital in Algiers.

Authors:  Y Messai; T Benhassine; M Naim; G Paul; R Bakour
Journal:  Rev Esp Quimioter       Date:  2006-06       Impact factor: 1.553

7.  Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.

Authors:  R Bonnet; C Dutour; J L Sampaio; C Chanal; D Sirot; R Labia; C De Champs; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

8.  Emergence and outbreaks of CTX-M beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital.

Authors:  Kelthoum Mamlouk; Ilhem Boutiba-Ben Boubaker; Valérie Gautier; Sophie Vimont; Bertrand Picard; Saida Ben Redjeb; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

9.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

10.  Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000.

Authors:  Christophe De Champs; Laurent Poirel; Richard Bonnet; Danielle Sirot; Catherine Chanal; Jacques Sirot; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more
  3 in total

1.  Characterization of two new CTX-M-25-group extended-spectrum β-lactamase variants identified in Escherichia coli isolates from Israel.

Authors:  Jascha Vervoort; Anna Baraniak; Muriel Gazin; Julia Sabirova; Christine Lammens; Meital Kazma; Anna Grabowska; Radosław Izdebski; Yehuda Carmeli; Samir Kumar-Singh; Marek Gniadkowski; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

2.  Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial -Escherichia coli infection in China.

Authors:  Huiqing Shi; Fengjun Sun; Jianhong Chen; Qianyi Ou; Wei Feng; Xiaolan Yong; Peiyuan Xia
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-01-16       Impact factor: 3.944

3.  bla CTX-M-152, a Novel Variant of CTX-M-group-25, Identified in a Study Performed on the Prevalence of Multidrug Resistance among Natural Inhabitants of River Yamuna, India.

Authors:  Mudsser Azam; Arif T Jan; Qazi M R Haq
Journal:  Front Microbiol       Date:  2016-02-23       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.